Regional variations of the living donor liver transplant experience in the United States
Living Donor Organ Transplantation, Page: 875-882
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
In this chapter we explore the state of live donor liver transplantation (LDLT) in the United States and the regional practice variations within this specialty. We begin with a brief overview of the history of LDLT and then discuss the current state. We show the expansion of the number of programs performing LDLT at significant volumes by region. There is confirmation of graft survival being positively affected by center volume in a recent era, however, graft survival is not significant. When looking at 90-day waitlist mortality, it appears that there is less mortality in centers with low-volume LDLT programs versus centers without an LDLT program in regions with low median MELD score at transplant. Additionally, there appears to be lower 90-day waitlist mortality in regions with higher median MELD score at transplant in centers that have high-volume LDLT programs as compared to centers without LDLT programs. This stresses the importance of having the capabilities for LDLT in different center settings. We also explore the regional differences in usage and outcomes of left lobe LDLT. We found that left lobe LDLT is concentrated in a few select regions as well as finding lower 1-year graft survival in left lobe LDLT in highly experienced centers. This may be due to these centers exploring the limits of the graft to recipient weight ratios as well as the challenging technical aspects of left lobe LDLT. We conclude with a robust discussion of the pathway forward to expansion of LDLT in the United States and offer a few unique perspectives on methods to achieve this.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know